Dexamethasone/Povidone Iodine

地塞米松/聚维酮碘

Report date: 2023/10/01 20:01:05

Base Information

Drug NameDexamethasone/Povidone Iodine
Drug Alias Name地塞米松聚维酮碘Povidone Iodine and Dexamethasone聚维酮碘/地塞米松Povidone Iodine/DexamethasoneDexamethasone and Povidone Iodine +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsOtitis ExternaConjunctivitis, ViralConjunctivitis, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[18] 
CombinationsYes DexamethasonePovidone iodine
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCls Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire
Active IndicationsN/A
Inactive IndicationsOtitis ExternaConjunctivitis, ViralConjunctivitis, Bacterial

Other Information

ATC CodeN/A
Related LinksN/A